Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei Li Kuang

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Medical Clinics of North America|November 24, 2019
Approach to Patients with EosinophiliaFei Li Kuang
Seminars in Immunopathology|April 23, 2021
Lessons learned from targeting eosinophils in human diseaseFei Li Kuang, Bruce S Bochner
Journal of Leukocyte Biology|August 30, 2024
Advancing toward a unified eosinophil signature from transcriptional profilingKrishan D Chhiba, Fei Li Kuang
The Journal of Allergy and Clinical Immunology. in Practice|November 11, 2017
Biologic Agents for the Treatment of Hypereosinophilic SyndromesFei Li Kuang, Amy D Klion
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2009
H3 trimethyl K9 and H3 acetyl K9 chromatin modifications are associated with class switch recombinationFei Li Kuang, Zhonghui Luo, Matthew D Scharff
The Journal of Allergy and Clinical Immunology. in Practice|July 28, 2023
Biologics and Hypereosinophilic Syndromes: Knowledge Gaps and ControversiesFei Li Kuang, Paneez Khoury, Peter F Weller, et al.
The Journal of Allergy and Clinical Immunology. Global|June 1, 2026
Circulating eosinophils in patients with hypereosinophilic syndrome have heterogeneous immunophenotypesKrishan D Chhiba, Richard Kasjanski, Michelle A Makiya, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 22, 2025
Long-Term Efficacy and Safety of Benralizumab Treatment for PDGFRA-Negative Hypereosinophilic SyndromeFei Li Kuang, Michelle A Makiya, JeanAnne M Ware, et al.
Annual Review of Immunology|February 29, 2008
The biochemistry of somatic hypermutationJonathan U Peled, Fei Li Kuang, Maria D Iglesias-Ussel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 25, 2024
Eosinophilia and Adverse Effects of Dupilumab for Respiratory Indications: A Real-World SettingSylvia H Li, Katharine Foster Nehme, Anna Moshkovich, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Medical Clinics of North America|November 24, 2019
Approach to Patients with EosinophiliaFei Li Kuang
Seminars in Immunopathology|April 23, 2021
Lessons learned from targeting eosinophils in human diseaseFei Li Kuang, Bruce S Bochner
Journal of Leukocyte Biology|August 30, 2024
Advancing toward a unified eosinophil signature from transcriptional profilingKrishan D Chhiba, Fei Li Kuang
The Journal of Allergy and Clinical Immunology. in Practice|November 11, 2017
Biologic Agents for the Treatment of Hypereosinophilic SyndromesFei Li Kuang, Amy D Klion
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2009
H3 trimethyl K9 and H3 acetyl K9 chromatin modifications are associated with class switch recombinationFei Li Kuang, Zhonghui Luo, Matthew D Scharff
The Journal of Allergy and Clinical Immunology. in Practice|July 28, 2023
Biologics and Hypereosinophilic Syndromes: Knowledge Gaps and ControversiesFei Li Kuang, Paneez Khoury, Peter F Weller, et al.
The Journal of Allergy and Clinical Immunology. Global|June 1, 2026
Circulating eosinophils in patients with hypereosinophilic syndrome have heterogeneous immunophenotypesKrishan D Chhiba, Richard Kasjanski, Michelle A Makiya, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 22, 2025
Long-Term Efficacy and Safety of Benralizumab Treatment for PDGFRA-Negative Hypereosinophilic SyndromeFei Li Kuang, Michelle A Makiya, JeanAnne M Ware, et al.
Annual Review of Immunology|February 29, 2008
The biochemistry of somatic hypermutationJonathan U Peled, Fei Li Kuang, Maria D Iglesias-Ussel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 25, 2024
Eosinophilia and Adverse Effects of Dupilumab for Respiratory Indications: A Real-World SettingSylvia H Li, Katharine Foster Nehme, Anna Moshkovich, et al.
Pageof 3